BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17556902)

  • 1. Rugal hyperplastic gastritis increases the risk of gastric carcinoma, especially diffuse and p53-independent subtypes.
    Oguri A; Ohmiya N; Taguchi A; Itoh A; Hirooka Y; Niwa Y; Maeda O; Ando T; Goto H
    Eur J Gastroenterol Hepatol; 2007 Jul; 19(7):561-6. PubMed ID: 17556902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity of atrophic gastritis related to antiparietal cell antibody and gastric carcinogenesis, including p53 mutations.
    Taguchi A; Ohmiya N; Itoh A; Hirooka Y; Niwa Y; Mori N; Goto H
    J Gastroenterol Hepatol; 2006 Mar; 21(3):545-51. PubMed ID: 16638096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan.
    Taguchi A; Ohmiya N; Shirai K; Mabuchi N; Itoh A; Hirooka Y; Niwa Y; Goto H
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2487-93. PubMed ID: 16284368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrophy-metaplasia-dysplasia-carcinoma sequence in the stomach: a reality or merely an hypothesis?
    Meining A; Morgner A; Miehlke S; Bayerdörffer E; Stolte M
    Best Pract Res Clin Gastroenterol; 2001 Dec; 15(6):983-98. PubMed ID: 11866488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference of p53AIP1 mRNA expression in gastric mucosa between patients with gastric cancer and chronic gastritis infected with Helicobacter pylori.
    Sawaya M; Yoshimura T; Shimoyama T; Munakata A; Fukuda S
    J Clin Gastroenterol; 2008 Apr; 42(4):351-5. PubMed ID: 18277906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between tumour necrosis factor-alpha gene polymorphism and the susceptibility to rugal hyperplastic gastritis and gastric carcinoma.
    Ohyama I; Ohmiya N; Niwa Y; Shirai K; Taguchi A; Itoh A; Hirooka Y; Wakai K; Hamajima N; Mori N; Goto H
    Eur J Gastroenterol Hepatol; 2004 Jul; 16(7):693-700. PubMed ID: 15201584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KRAS mutations predict progression of preneoplastic gastric lesions.
    Gong C; Mera R; Bravo JC; Ruiz B; Diaz-Escamilla R; Fontham ET; Correa P; Hunt JD
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):167-71. PubMed ID: 10067815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence and risk factors for benign epithelial gastric polyps in atrophic body gastritis on diagnosis and follow-up.
    Di Giulio E; Lahner E; Micheletti A; Milione M; D'Ambra G; Bordi C; Delle Fave G; Annibale B
    Aliment Pharmacol Ther; 2005 Mar; 21(5):567-74. PubMed ID: 15740540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 Codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis.
    Hiyama T; Tanaka S; Kitadai Y; Ito M; Sumii M; Yoshihara M; Shimamoto F; Haruma K; Chayama K
    Int J Cancer; 2002 Jul; 100(3):304-8. PubMed ID: 12115545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atrophic gastritis caused by Helicobacter pylori as a precancer disease].
    Sklianskaia OA; Lapina TL
    Arkh Patol; 2004; 66(6):57-60. PubMed ID: 15648171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is interleukin-1 genotyping useful for the clinical management of patients with atrophic body gastritis?
    Lahner E; Corleto VD; D'Ambra G; Di Giulio E; Delle Fave G; Annibale B
    Aliment Pharmacol Ther; 2008 Feb; 27(4):355-65. PubMed ID: 18047563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diet, Helicobacter pylori, and p53 mutations in gastric cancer: a molecular epidemiology study in Italy.
    Palli D; Caporaso NE; Shiao YH; Saieva C; Amorosi A; Masala G; Rice JM; Fraumeni JF
    Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1065-9. PubMed ID: 9419404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The BB genotype of heat-shock protein (HSP) 70-2 gene is associated with gastric pre-malignant condition in H. pylori-infected older patients.
    Tahara T; Shibata T; Arisawa T; Nakamura M; Yoshioka D; Okubo M; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nagasaka M; Iwata M; Yamashita H; Nakano H; Hirata I
    Anticancer Res; 2009 Aug; 29(8):3453-8. PubMed ID: 19661373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interferon gamma receptor 1 (IFNGR1) -56C/T gene polymorphism is associated with increased risk of early gastric carcinoma.
    Canedo P; Corso G; Pereira F; Lunet N; Suriano G; Figueiredo C; Pedrazzani C; Moreira H; Barros H; Carneiro F; Seruca R; Roviello F; Machado JC
    Gut; 2008 Nov; 57(11):1504-8. PubMed ID: 18593809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
    Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
    Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA repair polymorphisms and the risk of stomach adenocarcinoma and severe chronic gastritis in the EPIC-EURGAST study.
    Capellá G; Pera G; Sala N; Agudo A; Rico F; Del Giudicce G; Plebani M; Palli D; Boeing H; Bueno-de-Mesquita HB; Carneiro F; Berrino F; Vineis P; Tumino R; Panico S; Berglund G; Simán H; Nyrén O; Hallmans G; Martinez C; Dorronsoro M; Barricarte A; Navarro C; Quirós JR; Allen N; Key T; Bingham S; Caldas C; Linseisen J; Nagel G; Overvad K; Tjonneland A; Boshuizen HC; Peeters PH; Numans ME; Clavel-Chapelon F; Trichopoulou A; Lund E; Jenab M; Kaaks R; Riboli E; González CA
    Int J Epidemiol; 2008 Dec; 37(6):1316-25. PubMed ID: 18641418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-parietal cell antibody and serum pepsinogen assessment in screening for gastric carcinoma.
    Sugiu K; Kamada T; Ito M; Kaya S; Tanaka A; Kusunoki H; Hata J; Haruma K
    Dig Liver Dis; 2006 May; 38(5):303-7. PubMed ID: 16549394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A topographic analysis of atrophic gastritis and stomach cancer risk. A clinicoepidemiological study in Poland.
    Jedrychowski W; Popiela T; Steindorf K; Matyja A; Gryglewski A; Nowak K; Kieltyka A; Wahrendorf J; Becher H
    Cent Eur J Public Health; 1997 Sep; 5(3):117-21. PubMed ID: 9386896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gastritis and stomach cancer--epidemiologic correlation].
    Siurala M; Sipponen P; Kekki M
    Leber Magen Darm; 1984 Jul; 14(4):139-48. PubMed ID: 6332962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastritis and gastric atrophy.
    El-Zimaity H
    Curr Opin Gastroenterol; 2008 Nov; 24(6):682-6. PubMed ID: 19122515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.